Dietze K, Nguyen K, Pathni A, Fazekas F, Baker J, Gebru E
bioRxiv. 2024; .
PMID: 38915559
PMC: 11195252.
DOI: 10.1101/2024.06.11.598379.
Spiwokova P, Horn M, Fanfrlik J, Jilkova A, Fajtova P, Leontovyc A
ACS Infect Dis. 2024; 10(6):1935-1948.
PMID: 38757505
PMC: 11184554.
DOI: 10.1021/acsinfecdis.3c00589.
Yoon M, Phan V, Podvin S, Mosier C, ODonoghue A, Hook V
Biochemistry. 2023; 62(15):2289-2300.
PMID: 37459182
PMC: 10399199.
DOI: 10.1021/acs.biochem.3c00139.
Zhou L, He F, Xiang X, Dong C, Xiang T, Li X
Mol Pharm. 2023; 20(7):3539-3548.
PMID: 37289648
PMC: 10324598.
DOI: 10.1021/acs.molpharmaceut.3c00148.
Zabiegala A, Kim Y, Chang K
Anim Dis. 2023; 3(1):12.
PMID: 37128508
PMC: 10125864.
DOI: 10.1186/s44149-023-00075-x.
Cathepsin-B inhibitor CA-074 attenuates retinopathy and optic neuritis in experimental autoimmune encephalomyelitis induced in SJL/J mice.
Khan M, Fayaz Ahmad S, Nadeem A, Imam F, Al-Harbi N, Khan M
Saudi Pharm J. 2023; 31(1):147-153.
PMID: 36685301
PMC: 9845124.
DOI: 10.1016/j.jsps.2022.11.013.
Elucidation of chemical profiles and molecular targets of Mondia whitei leave fractions bioactive as novel therapeutics: an in vitro and in silico assay.
Onohuean H, Onohuean F, Igbinoba S, Ezeonwumelu J, Agu P, Ifie J
J Genet Eng Biotechnol. 2022; 20(1):170.
PMID: 36574159
PMC: 9794650.
DOI: 10.1186/s43141-022-00440-2.
Structure determinants defining the specificity of papain-like cysteine proteases.
Petushkova A, Savvateeva L, Zamyatnin Jr A
Comput Struct Biotechnol J. 2022; 20:6552-6569.
PMID: 36467578
PMC: 9712828.
DOI: 10.1016/j.csbj.2022.11.040.
Caspase-1 and Cathepsin B Inhibitors from Marine Invertebrates, Aiming at a Reduction in Neuroinflammation.
Moreno R, Zambelli V, Picolo G, Cury Y, Morandini A, Marques A
Mar Drugs. 2022; 20(10).
PMID: 36286438
PMC: 9604745.
DOI: 10.3390/md20100614.
Cathepsin B and Plasma Kallikrein Are Reliable Biomarkers to Discriminate Clinically Significant Hepatic Fibrosis in Patients with Chronic Hepatitis-C Infection.
Zanelatto A, Lacerda G, Accardo C, Rosario N, da Silva A, Motta G
Microorganisms. 2022; 10(9).
PMID: 36144371
PMC: 9501310.
DOI: 10.3390/microorganisms10091769.
Discovery of pH-Selective Marine and Plant Natural Product Inhibitors of Cathepsin B Revealed by Screening at Acidic and Neutral pH Conditions.
Phan V, Mosier C, Yoon M, Glukhov E, Caffrey C, ODonoghue A
ACS Omega. 2022; 7(29):25346-25352.
PMID: 35910167
PMC: 9330179.
DOI: 10.1021/acsomega.2c02287.
Cathepsin B Gene Knockout Improves Behavioral Deficits and Reduces Pathology in Models of Neurologic Disorders.
Hook G, Reinheckel T, Ni J, Wu Z, Kindy M, Peters C
Pharmacol Rev. 2022; 74(3):600-629.
PMID: 35710131
PMC: 9553114.
DOI: 10.1124/pharmrev.121.000527.
Photoresponsive Small Molecule Inhibitors for the Remote Control of Enzyme Activity.
Laczi D, Johnstone M, Fleming C
Chem Asian J. 2022; 17(11):e202200200.
PMID: 35446477
PMC: 9322446.
DOI: 10.1002/asia.202200200.
Lysosomal ceramides regulate cathepsin B-mediated processing of saposin C and glucocerebrosidase activity.
Kim M, Jeong H, Krainc D
Hum Mol Genet. 2022; 31(14):2424-2437.
PMID: 35181782
PMC: 9307309.
DOI: 10.1093/hmg/ddac047.
Molecular Features of CA-074 pH-Dependent Inhibition of Cathepsin B.
Yoon M, Christy M, Phan V, Gerwick W, Hook G, ODonoghue A
Biochemistry. 2022; 61(4):228-238.
PMID: 35119840
PMC: 9096814.
DOI: 10.1021/acs.biochem.1c00684.
Selective Neutral pH Inhibitor of Cathepsin B Designed Based on Cleavage Preferences at Cytosolic and Lysosomal pH Conditions.
Yoon M, Solania A, Jiang Z, Christy M, Podvin S, Mosier C
ACS Chem Biol. 2021; 16(9):1628-1643.
PMID: 34416110
PMC: 9104225.
DOI: 10.1021/acschembio.1c00138.
The Role of Cathepsin B in the Degradation of Aβ and in the Production of Aβ Peptides Starting With Ala2 in Cultured Astrocytes.
Oberstein T, Utz J, Spitzer P, Klafki H, Wiltfang J, Lewczuk P
Front Mol Neurosci. 2021; 13:615740.
PMID: 33510618
PMC: 7836726.
DOI: 10.3389/fnmol.2020.615740.
MAIT cell activation augments adenovirus vector vaccine immunogenicity.
Provine N, Amini A, Garner L, Spencer A, Dold C, Hutchings C
Science. 2021; 371(6528):521-526.
PMID: 33510029
PMC: 7610941.
DOI: 10.1126/science.aax8819.
WIDOCK: a reactive docking protocol for virtual screening of covalent inhibitors.
Scarpino A, Petri L, Knez D, Imre T, Abranyi-Balogh P, Ferenczy G
J Comput Aided Mol Des. 2021; 35(2):223-244.
PMID: 33458809
PMC: 7904743.
DOI: 10.1007/s10822-020-00371-5.
Current Status and Perspectives of Protease Inhibitors and Their Combination with Nanosized Drug Delivery Systems for Targeted Cancer Therapy.
Rudzinska M, Daglioglu C, Savvateeva L, Kaci F, Antoine R, Zamyatnin Jr A
Drug Des Devel Ther. 2021; 15:9-20.
PMID: 33442233
PMC: 7797289.
DOI: 10.2147/DDDT.S285852.